In this study, we found that HBP1 expression level was enhanced in βTC3 cells by SHG or IHG treatment and in T2DM mouse model, together with the inhibition of Wnt/β-catenin pathway. The gene discussed is HBP1; the disease is type 2 diabetes mellitus.